InMed Pharmaceuticals is a clinical stage pharmaceutical company engageing in the research and development of novel, cannabinoid-based therapies and an integrated system for the manufacturing of pharmaceutical-grade cannabinoids. We show 10 historical shares outstanding datapoints in our coverage of INM's shares outstanding history.
Understanding the changing numbers of INM shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like INM versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching INM by allowing them to research INM shares outstanding history
as well as any other stock in our coverage universe. |
Free INM Email Alerts:
Video: Shares Outstanding Importance
